Hsp90 inhibitors
US-10064867-B2 · Sep 4, 2018 · US
Hsp9O-targeted inflammation and infection imaging and therapy
US10617772B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10617772-B2 |
| Application number | US-201515511701-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 17, 2015 |
| Priority date | Sep 17, 2014 |
| Publication date | Apr 14, 2020 |
| Grant date | Apr 14, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides new methods for inflammation and infection imaging and related medical applications thereof. In some embodiments, the present invention provides a method for the diagnosis of inflammation and/or infection. In some embodiments, the present invention provides a method for the treatment or prevention of inflammation and/or infection. In some embodiments, the present invention provides methods for monitoring the effect of inflammation and/or infection treatment, and/or methods for monitoring an inflammation and/or infection treatment regimen. In some embodiments, the present invention provides a method for selecting subjects for an inflammation and/or infection treatment. In some embodiments, the present invention provides a method for determining the dosage of a drug for the treatment of inflammation and/or infection.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for the treatment of inflammation of the brain comprising the step of administering to a subject in need thereof a compound having the formula: wherein the inflammation of the brain is not caused by cancer. 2. The method of claim 1 , wherein the method further comprises administration of anti-inflammatory agents, antihistamines, immunosuppressive agents, anti-viral agents, anti-fungal agents, antibacterial agents, anti-parasitic agents, or a combination thereof. 3. The method of claim 1 , wherein the inflammation of the brain is the result of brain trauma. 4. The method of claim 2 , wherein the administration of the anti-inflammatory agents, antihistamines, immunosuppressive agent, anti-viral agents, anti-fungal agents, antibacterial agents, anti-parasitic agents or a combination thereof is subsequent to or prior to the administration of the compound of claim 1 .
Assignees
Inventors
Classifications
for diagnosis of the heart · CPC title
Antineoplastic agents · CPC title
related to combined acquisition of different diagnostic modalities · CPC title
involving acquisition triggered by a physiological signal · CPC title
Purines, e.g. adenine · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10617772B2 cover?
- The present invention provides new methods for inflammation and infection imaging and related medical applications thereof. In some embodiments, the present invention provides a method for the diagnosis of inflammation and/or infection. In some embodiments, the present invention provides a method for the treatment or prevention of inflammation and/or infection. In some embodiments, the present …
- Who is the assignee on this patent?
- Memorial Sloan Kettering Cancer Center
- What technology area does this patent fall under?
- Primary CPC classification A61K51/0459. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).